DYNAVAX TECHNOLOGIES news, videos and press releases
For more news please use our advanced search feature.
DYNAVAX TECHNOLOGIES - More news...
DYNAVAX TECHNOLOGIES - More news...
- Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
- Deep Track Capital Releases Investor Presentation on Dynavax Technologies
- Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits
- Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
- Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
- Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
- Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer
- Dynavax Files Preliminary Proxy Statement
- Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
- Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
- Dynavax to Participate in Upcoming Investor Conferences
- Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance
- Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
- Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
- Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025
- Dynavax Advances Board Refreshment Program
- Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
- Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
- Dynavax Announces $100 Million Accelerated Share Repurchase Program
- Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
- Dynavax Announces $200 Million Share Repurchase Program
- Dynavax Adopts Limited-Duration Stockholder Rights Plan
- Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
- Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
- Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program
- Dynavax to Present at Upcoming Investor Conferences
- Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.
- Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
- Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
